APO Research
Talk to an analyst

APO RESEARCH · REPORT

Infectious Bursal Disease Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Infectious Bursal Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026196 pages

Choose your research edition.

Industry ResearchInfectious Bursal Disease Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Infectious Bursal Disease Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Infectious Bursal Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Infectious Bursal Disease Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Infectious Bursal Disease Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Infectious Bursal Disease Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Infectious Bursal Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Infectious Bursal Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Infectious Bursal Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Infectious Bursal Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Infectious Bursal Disease Vaccine include Shandong Lvdu Biological Technology Co., Ltd., Ruipu Biopharmaceutical Co., Ltd., Qingdao Yibang Biological Engineering Co., Ltd., Plyco Bioengineering Co., Ltd., Merck, Harbin Pharmaceutical Group Biological Vaccine Co., Ltd., Zoetis, Elanco and Ceva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Infectious Bursal Disease Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Infectious Bursal Disease Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Infectious Bursal Disease Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Infectious Bursal Disease Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Infectious Bursal Disease Vaccine Segment by Company

Shandong Lvdu Biological Technology Co., Ltd.

Ruipu Biopharmaceutical Co., Ltd.

Qingdao Yibang Biological Engineering Co., Ltd.

Plyco Bioengineering Co., Ltd.

Merck

Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

Zoetis

Elanco

Ceva

Boehringer Ingelheim

Infectious Bursal Disease Vaccine Segment by Type

Live

Inactivated

Infectious Bursal Disease Vaccine Segment by Application

Veterinary Pharmacy

Online Sale

Others

Infectious Bursal Disease Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infectious Bursal Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infectious Bursal Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infectious Bursal Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Infectious Bursal Disease Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Infectious Bursal Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Infectious Bursal Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Infectious Bursal Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Infectious Bursal Disease Vaccine Industry Trends Table 2. Infectious Bursal Disease Vaccine Industry Drivers Table 3. Infectious Bursal Disease Vaccine Industry Opportunities and Challenges Table 4. Infectious Bursal Disease Vaccine Industry Restraints Table 5. Global Infectious Bursal Disease Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Infectious Bursal Disease Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Infectious Bursal Disease Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Infectious Bursal Disease Vaccine Sales Market Share by Manufacturers Table 9. Global Infectious Bursal Disease Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Infectious Bursal Disease Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Infectious Bursal Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Infectious Bursal Disease Vaccine Manufacturers, Product Type & Application Table 13. Global Infectious Bursal Disease Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Infectious Bursal Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Live Table 17. Major Manufacturers of Inactivated Table 18. Global Infectious Bursal Disease Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Infectious Bursal Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Infectious Bursal Disease Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Infectious Bursal Disease Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Infectious Bursal Disease Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Veterinary Pharmacy Table 29. Major Manufacturers of Online Sale Table 30. Major Manufacturers of Others Table 31. Global Infectious Bursal Disease Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 33. Global Infectious Bursal Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 34. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Infectious Bursal Disease Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Infectious Bursal Disease Vaccine Revenue by Application (2021-2026) & (K Units) Table 38. Global Infectious Bursal Disease Vaccine Revenue by Application (2027-2032) & (K Units) Table 39. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Infectious Bursal Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Infectious Bursal Disease Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Infectious Bursal Disease Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Infectious Bursal Disease Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Infectious Bursal Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 48. North America Infectious Bursal Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 49. Europe Infectious Bursal Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 51. Europe Infectious Bursal Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Infectious Bursal Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Infectious Bursal Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Infectious Bursal Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 58. Global Infectious Bursal Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Infectious Bursal Disease Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Infectious Bursal Disease Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2027-2032) Table 63. Shandong Lvdu Biological Technology Co., Ltd. Company Information Table 64. Shandong Lvdu Biological Technology Co., Ltd. Business Overview Table 65. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 67. Shandong Lvdu Biological Technology Co., Ltd. Recent Development Table 68. Ruipu Biopharmaceutical Co., Ltd. Company Information Table 69. Ruipu Biopharmaceutical Co., Ltd. Business Overview Table 70. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 72. Ruipu Biopharmaceutical Co., Ltd. Recent Development Table 73. Qingdao Yibang Biological Engineering Co., Ltd. Company Information Table 74. Qingdao Yibang Biological Engineering Co., Ltd. Business Overview Table 75. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 77. Qingdao Yibang Biological Engineering Co., Ltd. Recent Development Table 78. Plyco Bioengineering Co., Ltd. Company Information Table 79. Plyco Bioengineering Co., Ltd. Business Overview Table 80. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 82. Plyco Bioengineering Co., Ltd. Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Merck Infectious Bursal Disease Vaccine Product Portfolio Table 87. Merck Recent Development Table 88. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information Table 89. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview Table 90. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 92. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Development Table 93. Zoetis Company Information Table 94. Zoetis Business Overview Table 95. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Zoetis Infectious Bursal Disease Vaccine Product Portfolio Table 97. Zoetis Recent Development Table 98. Elanco Company Information Table 99. Elanco Business Overview Table 100. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Elanco Infectious Bursal Disease Vaccine Product Portfolio Table 102. Elanco Recent Development Table 103. Ceva Company Information Table 104. Ceva Business Overview Table 105. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Ceva Infectious Bursal Disease Vaccine Product Portfolio Table 107. Ceva Recent Development Table 108. Boehringer Ingelheim Company Information Table 109. Boehringer Ingelheim Business Overview Table 110. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Portfolio Table 112. Boehringer Ingelheim Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Infectious Bursal Disease Vaccine Distributors List Table 116. Infectious Bursal Disease Vaccine Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Infectious Bursal Disease Vaccine Product Image Figure 2. Global Infectious Bursal Disease Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Infectious Bursal Disease Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Infectious Bursal Disease Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Infectious Bursal Disease Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Infectious Bursal Disease Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Live Image Figure 9. Inactivated Image Figure 10. Global Infectious Bursal Disease Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Infectious Bursal Disease Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Infectious Bursal Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Infectious Bursal Disease Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Veterinary Pharmacy Image Figure 17. Online Sale Image Figure 18. Others Image Figure 19. Global Infectious Bursal Disease Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Infectious Bursal Disease Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Infectious Bursal Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Infectious Bursal Disease Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Infectious Bursal Disease Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Infectious Bursal Disease Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Infectious Bursal Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Infectious Bursal Disease Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Infectious Bursal Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Infectious Bursal Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Infectious Bursal Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Infectious Bursal Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Infectious Bursal Disease Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Infectious Bursal Disease Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Live
  • Inactivated
Applications
  • Veterinary Pharmacy
  • Online Sale
  • Others
Companies covered
  • Shandong Lvdu Biological Technology Co., Ltd.
  • Ruipu Biopharmaceutical Co., Ltd.
  • Qingdao Yibang Biological Engineering Co., Ltd.
  • Plyco Bioengineering Co., Ltd.
  • Merck
  • Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
  • Zoetis
  • Elanco
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Infectious Bursal Disease Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Infectious Bursal Disease Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Infectious Bursal Disease Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Infectious Bursal Disease Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Infectious Bursal Disease Vaccine Market Dynamics
  1. 2.1 Infectious Bursal Disease Vaccine Industry Trends
  2. 2.2 Infectious Bursal Disease Vaccine Industry Drivers
  3. 2.3 Infectious Bursal Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Infectious Bursal Disease Vaccine Industry Restraints
3 Infectious Bursal Disease Vaccine Market by Manufacturers
  1. 3.1 Global Infectious Bursal Disease Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Infectious Bursal Disease Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Infectious Bursal Disease Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Infectious Bursal Disease Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Infectious Bursal Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Infectious Bursal Disease Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Infectious Bursal Disease Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Infectious Bursal Disease Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Infectious Bursal Disease Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Infectious Bursal Disease Vaccine Tier 1, Tier 2, and Tier 3
4 Infectious Bursal Disease Vaccine Market by Type
  1. 4.1 Infectious Bursal Disease Vaccine Type Introduction
  2. 4.1.1 Live
  3. 4.1.2 Inactivated
  4. 4.2 Global Infectious Bursal Disease Vaccine Sales by Type
  5. 4.2.1 Global Infectious Bursal Disease Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Infectious Bursal Disease Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Infectious Bursal Disease Vaccine Revenue by Type
  9. 4.3.1 Global Infectious Bursal Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Infectious Bursal Disease Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2021-2032)
5 Infectious Bursal Disease Vaccine Market by Application
  1. 5.1 Infectious Bursal Disease Vaccine Application Introduction
  2. 5.1.1 Veterinary Pharmacy
  3. 5.1.2 Online Sale
  4. 5.1.3 Others
  5. 5.2 Global Infectious Bursal Disease Vaccine Sales by Application
  6. 5.2.1 Global Infectious Bursal Disease Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Infectious Bursal Disease Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Infectious Bursal Disease Vaccine Revenue by Application
  10. 5.3.1 Global Infectious Bursal Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Infectious Bursal Disease Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2021-2032)
6 Global Infectious Bursal Disease Vaccine Sales by Region
  1. 6.1 Global Infectious Bursal Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Infectious Bursal Disease Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Infectious Bursal Disease Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Infectious Bursal Disease Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Infectious Bursal Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Infectious Bursal Disease Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Infectious Bursal Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Infectious Bursal Disease Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Infectious Bursal Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Infectious Bursal Disease Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Infectious Bursal Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Infectious Bursal Disease Vaccine Revenue by Region
  1. 7.1 Global Infectious Bursal Disease Vaccine Revenue by Region
  2. 7.1.1 Global Infectious Bursal Disease Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Infectious Bursal Disease Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Infectious Bursal Disease Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Infectious Bursal Disease Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Infectious Bursal Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Infectious Bursal Disease Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Infectious Bursal Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Infectious Bursal Disease Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Infectious Bursal Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Infectious Bursal Disease Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Infectious Bursal Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shandong Lvdu Biological Technology Co., Ltd.
  2. 8.1.1 Shandong Lvdu Biological Technology Co., Ltd. Company Information
  3. 8.1.2 Shandong Lvdu Biological Technology Co., Ltd. Business Overview
  4. 8.1.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  6. 8.1.5 Shandong Lvdu Biological Technology Co., Ltd. Recent Developments
  7. 8.2 Ruipu Biopharmaceutical Co., Ltd.
  8. 8.2.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Ruipu Biopharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  12. 8.2.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Qingdao Yibang Biological Engineering Co., Ltd.
  14. 8.3.1 Qingdao Yibang Biological Engineering Co., Ltd. Company Information
  15. 8.3.2 Qingdao Yibang Biological Engineering Co., Ltd. Business Overview
  16. 8.3.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  18. 8.3.5 Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments
  19. 8.4 Plyco Bioengineering Co., Ltd.
  20. 8.4.1 Plyco Bioengineering Co., Ltd. Company Information
  21. 8.4.2 Plyco Bioengineering Co., Ltd. Business Overview
  22. 8.4.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  24. 8.4.5 Plyco Bioengineering Co., Ltd. Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Infectious Bursal Disease Vaccine Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
  32. 8.6.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
  33. 8.6.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview
  34. 8.6.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  36. 8.6.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments
  37. 8.7 Zoetis
  38. 8.7.1 Zoetis Company Information
  39. 8.7.2 Zoetis Business Overview
  40. 8.7.3 Zoetis Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Zoetis Infectious Bursal Disease Vaccine Product Portfolio
  42. 8.7.5 Zoetis Recent Developments
  43. 8.8 Elanco
  44. 8.8.1 Elanco Company Information
  45. 8.8.2 Elanco Business Overview
  46. 8.8.3 Elanco Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Elanco Infectious Bursal Disease Vaccine Product Portfolio
  48. 8.8.5 Elanco Recent Developments
  49. 8.9 Ceva
  50. 8.9.1 Ceva Company Information
  51. 8.9.2 Ceva Business Overview
  52. 8.9.3 Ceva Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ceva Infectious Bursal Disease Vaccine Product Portfolio
  54. 8.9.5 Ceva Recent Developments
  55. 8.10 Boehringer Ingelheim
  56. 8.10.1 Boehringer Ingelheim Company Information
  57. 8.10.2 Boehringer Ingelheim Business Overview
  58. 8.10.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Portfolio
  60. 8.10.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Infectious Bursal Disease Vaccine Value Chain Analysis
  2. 9.1.1 Infectious Bursal Disease Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Infectious Bursal Disease Vaccine Production Mode & Process
  6. 9.2 Infectious Bursal Disease Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Infectious Bursal Disease Vaccine Distributors
  9. 9.2.3 Infectious Bursal Disease Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst